Yuhan Corporation signed a strategic partnership agreement with AstraZeneca Korea regard to joint sales of Crestor
On Mar 12, Yuhan Corporation announced that they signed a strategic partnership agreement with AstraZeneca Korea (CEO Liz chaeteuwin) regard to joint sales of no.1 statin drug Crestor (ingredient: rosuvastatin) in domestic.
Through this agreement, starting from March, both companies will begin s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
